Bioleaders Corporation (142760) — Cash Flow Quality Index
Bioleaders Corporation (142760) has a Cash Flow Quality Index of 21.06x as of June 2024. Operating cash flow of ₩19.27 Billion exceeds net income of ₩914.71 Million, indicating high earnings quality where cash backs reported profits. Explore 142760 debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Bioleaders Corporation Cash Flow Quality Index (2023–2023)
Historical Cash Flow Quality Index for Bioleaders Corporation across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see Bioleaders Corporation cash flow conversion.
Annual Cash Flow Quality Index for Bioleaders Corporation (2023–2023)
Year-by-year earnings quality comparison for Bioleaders Corporation.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2023 | 0.76x | ₩6.18 Billion | ₩8.07 Billion | — |